Clinical Trial Results:
A Phase 3, Randomized, Double-blind, Active-controlled, Parallel-group, Multi-center Study to Evaluate the Safety and Efficacy of Apixaban in Subjects Undergoing Elective Total Hip Replacement Surgery (The ADVANCE-3 study Apixaban Dosed Orally Versus Anti-Coagulation with Injectable Enoxaparin to Prevent Venous Thromboembolism)
+Pharmacogenetics Blood Sample Amendment 01 (Version 1.0 - dated 27-Nov-2006)
Revised Protocol 02, incorporating Protocol Amedment 02 & 04 and Admin Letter 01 (Version 3.0, Dated 21-Jun-2007)
Summary
|
|
EudraCT number |
2006-005351-14 |
Trial protocol |
DE SE FR BE GB DK HU ES |
Global completion date |
05 Sep 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
07 Dec 2016
|
First version publication date |
07 Dec 2016
|
Other versions |
|
Summary report(s) |
CV185-035_Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.